This note proposes a validation protocol to ensure control cohorts reflect national epidemiological standards, mitigating bias.
The proliferation of Big Medical Data has revolutionized observational epidemiology but introduced a significant risk of selection bias. This note proposes a primary validation protocol: the Consistency Delta Test. By comparing the baseline incidence of a control cohort against established national epidemiological benchmarks, researchers can identify fundamental discrepancies before comparative analysis. We demonstrate through three clinical cases, oncology, dermatology, and psychiatry, that when a control group deviates by more than a value of Delta (e.g., 20%) from national standards, the resulting risk estimates lose biological plausibility. This check is proposed as a mandatory prerequisite for ensuring that statistical signals are anchored in epidemiological reality
No takes yet. Share an insight, caveat, or question.
Marco Roccetti (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: